z-logo
open-access-imgOpen Access
Effects and Mechanisms of Checkpoint Inhibitors (CTLA-4, PD-1 and PD-L1 Inhibitors) as New Immunotherapeutic Agents for Bladder Cancer
Author(s) -
Serdar Çelik,
Zekiye Altun,
Safiye Aktaş
Publication year - 2018
Publication title -
bulletin of urooncology
Language(s) - English
Resource type - Journals
eISSN - 2147-2122
pISSN - 2147-2270
DOI - 10.4274/uob.947
Subject(s) - pd l1 , ctla 4 , immunotherapy , cancer research , immune checkpoint , bladder cancer , nivolumab , medicine , cancer , immune system , immunology , t cell

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom